Drug Trial Radar · NCT07086677
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
Last checked: Nov 19, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
380
Actual
Start
Jul 22, 2025
Primary completion
Oct 21, 2027
Study completion Oct 21, 2027
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jul 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years, up to 84 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn about the safety and tolerability of a pneumococcal vaccine in adults. Participants will receive either: * an experimental PG4 vaccine * a PG4 vaccine comparator * a standard 20vPnC vaccine comparator * placebo. A placebo does not have any medicine in it but looks just like the study medicine. Participants will take part in this study for up to 18 months depending on which group they are assigned to. During this time, the participants will receive up to two doses of study vaccine or comparator and take part in follow-up visits. At these clinic visits, participants will be asked if any side effects were experienced. The participants will also have to give blood samples during clinic visits.
Conditions
- Streptococcus Pneumoniae
Interventions
PG4 vaccine in Buffer 1 with low dose PA-001Biological
Multivalent pneumococcal conjugate vaccine
PG4 in Buffer 1 with low dose PA-002Biological
Multivalent pneumococcal conjugate vaccine
PG4 in Buffer 1 with high dose PA-001Biological
Multivalent pneumococcal conjugate vaccine
PG4 vaccine in Buffer 1 with high dose PA-002Biological
Multivalent pneumococcal conjugate vaccine
PG4 vaccine in Buffer 2Biological
Multivalent pneumococcal conjugate vaccine
20-valent pneumococcal conjugate vaccineBiological
(20vPnC)
Saline injectionBiological
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants reporting prespecified local reactions after each dose.Time frame: Within 7 days after each study intervention.
- Percentage of participants reporting prespecified systemic reactions after each dose.Time frame: Within 7 days after each study intervention.
- Percentage of participants reporting adverse events.Time frame: From signing of the ICD to 1 month after last study intervention.
- Percentage of participants reporting serious adverse events.Time frame: From signing of the ICD to 6 months after the last study intervention.
- Percentage of participants reporting serious adverse events.Time frame: From signing of the ICD to 12 months after the last study intervention.
- Percentage of participants with abnormal hematology and chemistry laboratory values.Time frame: Within 2 weeks after each study intervention.
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Orange County Research Center
Lake Forest, California
Peninsula Research Associates
Rolling Hills Estates, California
Finlay Medical Research
Greenacres City, Florida
Indago Research & Health Center, Inc.
Miami Lakes, Florida
Johnson County Clinical Trials
Lenexa, Kansas
Bio-Kinetic Clinical Applications, LLC dba QPS-MO
Springfield, Missouri
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center
Springfield, Missouri
Bio-Kinetic Clinical Applications, LLC dba QPS-MO
Springfield, Missouri
Velocity Clinical Research, Omaha
Omaha, Nebraska
Upstate Global Health Institute
East Syracuse, New York
NYU Langone Health Vaccine Center
New York, New York
Duke Vaccine and Trials Unit
Durham, North Carolina
CTI Clinical Research Center
Cincinnati, Ohio
Headlands Horizons, LLC dba Headlands Research-Brownsville
Brownsville, Texas
Valley Regional Medical Center
Brownsville, Texas
LabCorp
Houston, Texas
IMA Clinical Research San Antonio
San Antonio, Texas
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Tomball, Texas
J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.